AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR WITH RIBAVIRIN IN ADULTS WITH GENOTYPE 1 AND OMBITASVIR/PARITAPREVIR/RITONAVIR WITH RIBAVIRIN IN ADULTS WITH GENOTYPE 4 CHRONIC HEPATITIS C VIRUS INFECTION AND DECOMPENSATED CIRRHOSIS (TURQUOISE-CPB)
- Registry ID
- M14-227
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- ABBVIE CORPORATION
- Start date
- 2014-09-25
- Completion date
- 2017-03-03
- Last update
- 2014-08-13
Conditions
- HEPATITIS C VIRUS GENOTYPE 1
Related clinical trials
View on source registry